These medications work by mimicking the hormone GLP-1 to reduce appetite, slow gastric emptying, and improve insulin sensitivity
After obtaining informed consent from all participants, data regarding diagnoses, medications used, demographic characteristics, laboratory findings, and abdominal ultrasonography between December 2023 and December 2024 were retrieved from electronic medical records
Vet Pathol 20, 41023
Status of Other GLP-1 Products: As of February 21, 2025, the FDA is also monitoring other GLP-1 medications: Dulaglutide injection : Still in shortage, though the manufacturer has reported all presentations are available
D'Ascanio AM, Mullally JA, Frishman WH